Jan Lindebjerg

4.0k total citations · 1 hit paper
121 papers, 2.9k citations indexed

About

Jan Lindebjerg is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Jan Lindebjerg has authored 121 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Oncology, 42 papers in Surgery and 42 papers in Pathology and Forensic Medicine. Recurrent topics in Jan Lindebjerg's work include Colorectal Cancer Treatments and Studies (43 papers), Colorectal Cancer Surgical Treatments (41 papers) and Genetic factors in colorectal cancer (41 papers). Jan Lindebjerg is often cited by papers focused on Colorectal Cancer Treatments and Studies (43 papers), Colorectal Cancer Surgical Treatments (41 papers) and Genetic factors in colorectal cancer (41 papers). Jan Lindebjerg collaborates with scholars based in Denmark, United States and United Kingdom. Jan Lindebjerg's co-authors include Anders Jakobsen, Torben Frøstrup Hansen, Lars Henrik Jensen, Søren Rafael Rafaelsen, John Pløen, Flemming Brandt Sørensen, Ane Appelt, Jens Christian Riis Jørgensen, Sanne Kjær‐Frifeldt and Karen‐Lise Garm Spindler and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jan Lindebjerg

117 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study

2015 367 citations Ane Appelt, John Pløen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Lindebjerg Denmark	31	1.9k	1.0k	752	678	602	121	2.9k
Shuntaro Obi Japan	28	619 0.3×	987 1.0×	572 0.8×	412 0.6×	557 0.9×	81	4.3k
Günther Gruber Switzerland	15	1.7k 0.9×	421 0.4×	1.8k 2.4×	513 0.8×	556 0.9×	24	3.2k
Kjell M. Tveit Norway	30	1.6k 0.8×	1.2k 1.2×	437 0.6×	642 0.9×	526 0.9×	79	2.8k
Cornelis JH van de Velde Netherlands	20	2.5k 1.3×	2.1k 2.1×	381 0.5×	433 0.6×	1.7k 2.8×	25	4.3k
Aaron R. Sasson United States	33	2.1k 1.1×	1.2k 1.2×	809 1.1×	844 1.2×	646 1.1×	82	3.4k
Jörg Nährig Germany	27	650 0.3×	363 0.4×	444 0.6×	636 0.9×	486 0.8×	51	2.1k
Susana Roselló Spain	31	2.3k 1.2×	686 0.7×	859 1.1×	885 1.3×	1.0k 1.7×	89	3.6k
Arndt Vogel Germany	8	831 0.4×	616 0.6×	799 1.1×	730 1.1×	730 1.2×	19	3.8k
A. E. Giuliano United States	29	1.3k 0.7×	1.0k 1.0×	1.5k 2.0×	699 1.0×	640 1.1×	51	3.2k
Eui Kyu Chie South Korea	31	2.4k 1.2×	1.4k 1.4×	989 1.3×	494 0.7×	1.4k 2.3×	233	3.9k

Countries citing papers authored by Jan Lindebjerg

Since Specialization

Citations

This map shows the geographic impact of Jan Lindebjerg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lindebjerg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lindebjerg more than expected).

Fields of papers citing papers by Jan Lindebjerg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Lindebjerg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lindebjerg. The network helps show where Jan Lindebjerg may publish in the future.

Co-authorship network of co-authors of Jan Lindebjerg

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Lindebjerg. A scholar is included among the top collaborators of Jan Lindebjerg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Lindebjerg. Jan Lindebjerg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

García‐Rodríguez, Juan L., Sanne Kjær‐Frifeldt, Jan Lindebjerg, et al.. (2025). The prognostic potential of RNA in stage II colon cancer: Insights from a screened multicenter population‐based cohort study. International Journal of Cancer. 157(8). 1746–1755.

García‐Rodríguez, Juan L., Theresa Jakobsen, Ulvi Ahmadov, et al.. (2024). The Transcriptional Landscape of Coding and Noncoding RNAs in Recurrent and Nonrecurrent Colon Cancer. American Journal Of Pathology. 194(8). 1424–1442. 3 indexed citations

Terkelsen, Thilde, Fabian Coscia, Sophia Doll, et al.. (2023). Proteomic Profiling of Colorectal Adenomas Identifies a Predictive Risk Signature for Development of Metachronous Advanced Colorectal Neoplasia. Gastroenterology. 165(1). 121–132.e5. 18 indexed citations

Hansen, Torben Frøstrup, et al.. (2023). Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study. Acta Oncologica. 62(9). 1066–1075. 4 indexed citations

Rafaelsen, Søren Rafael, Claus Dam, Hans B. Rahr, et al.. (2022). ESGAR 2022 Book of Abstracts. Insights into Imaging. 13(S2). 92–92. 1 indexed citations

Rafaelsen, Søren Rafael, Claus Dam, Hans B. Rahr, et al.. (2022). CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study. Current Oncology. 29(2). 1069–1079. 21 indexed citations

Pedersen, Malene Roland Vils, Søren Rafael Rafaelsen, Jan Lindebjerg, Torben Frøstrup Hansen, & Hans B. Rahr. (2021). The Impact of Patient Characteristics and Tumor Biology on the Accuracy of Preoperative Staging of Colon Cancer in Denmark. A Nationwide Cohort Study. Cancers. 13(17). 4384–4384. 6 indexed citations

Bundgaard, Lars, et al.. (2021). Intracorporeal anastomosis in right hemicolectomy for colon cancer: short-term outcomes with the DaVinci Xi robot. Journal of Robotic Surgery. 15(6). 915–922. 8 indexed citations

Hansen, Torben Frøstrup, Eva Fernebro, John Pløen, et al.. (2021). Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations. International Journal of Cancer. 149(1). 119–126. 10 indexed citations

10.

Rafaelsen, Søren Rafael, et al.. (2020). The impact of mismatch repair status to the preoperative staging of colon cancer: implications for clinical management. University of Southern Denmark Research Portal (University of Southern Denmark). 9(2). 5 indexed citations

11.

Jensen, Lars Henrik, Laurids Østergaard Poulsen, Signe Risum, et al.. (2020). 400MO Curative chemoradiation for low rectal cancer: Early clinical outcomes from a multicentre phase II trial. Annals of Oncology. 31. S411–S411. 2 indexed citations

12.

Jensen, Lars Henrik, Anders Kindberg Boysen, Rikke Fredslund Andersen, et al.. (2019). NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer. Cancers. 11(11). 1649–1649. 20 indexed citations

13.

Pedersen, Malene Roland Vils, Catherine Horsfield, Jan Lindebjerg, et al.. (2018). Testicular microlithiasis in patients with testicular cancer in the United Kingdom and in Denmark.. PubMed. 65(3). 8 indexed citations

14.

Andersen, Rikke Fredslund, et al.. (2018). Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment. Clinical Colorectal Cancer. 18(1). 28–33.e3. 9 indexed citations

15.

Jensen, Lars Henrik, Jan Lindebjerg, John Pløen, Torben Frøstrup Hansen, & Anders Jakobsen. (2012). Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer. Annals of Oncology. 23(9). 2341–2346. 75 indexed citations

16.

Hansen, Torben Frøstrup, Claus L. Andersen, Boye Schnack Nielsen, et al.. (2011). Elevated microRNA-126 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in colorectal cancer. Oncology Letters. 2(6). 1101–1106. 24 indexed citations

17.

Lindebjerg, Jan, K.-L.G. Spindler, John Pløen, & Anders Jakobsen. (2008). The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long‐course preoperative chemoradiotherapy. Colorectal Disease. 11(3). 264–269. 39 indexed citations

18.

Jensen, Lars Henrik, Jan Lindebjerg, Dorthe Gylling Crüger, et al.. (2008). Microsatellite Instability and the Association with Plasma Homocysteine and Thymidylate Synthase in Colorectal Cancer. Cancer Investigation. 26(6). 583–589. 10 indexed citations

19.

Spindler, Karen‐Lise Garm, et al.. (2006). Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region. International Journal of Radiation Oncology*Biology*Physics. 66(2). 500–504. 49 indexed citations

20.

Jakobsen, Anders, et al.. (2005). Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost. International Journal of Radiation Oncology*Biology*Physics. 64(2). 461–465. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact